Great Basin Scientific Announces Commercial Launch of Bordetella Direct Test
May 16, 2017 07:00 ET | Great Basin Scientific, Inc.
SALT LAKE CITY, May 16, 2017 (GLOBE NEWSWIRE) -- Great Basin Scientific, Inc. (OTCQB:GBSN), a molecular diagnostics company, today announced the U.S. commercial launch of its Bordetella Direct Test...
Great Basin Scientific Receives FDA 510(k) Clearance for Bordetella Direct Test
April 03, 2017 16:00 ET | Great Basin Scientific, Inc.
SALT LAKE CITY, April 03, 2017 (GLOBE NEWSWIRE) -- Great Basin Scientific, Inc. (OTCQB:GBSN), a molecular diagnostics company, has received U.S. Food & Drug Administration (FDA) clearance for...
Great Basin Scientific Completes Clinical Trial, Submits FDA 510(k) Application for Bordetella Direct Test
February 01, 2017 07:00 ET | Great Basin Scientific, Inc.
SALT LAKE CITY, Feb. 01, 2017 (GLOBE NEWSWIRE) -- Great Basin Scientific, Inc. (OTCQB:GBSN), a molecular diagnostics company, today announced the completion of the clinical trial and 510(k)...
New Monograph From The Joint Commission Aims to Increase Tdap Vaccination of Adults and Adolescents
February 01, 2011 12:55 ET | The Joint Commission
OAKBROOK TERRACE, IL--(Marketwire - February 1, 2011) -  Pertussis rates have increased over the last two decades, primarily in adolescents and adults who have waning immunity from previous...